Well-designed case–control studies with larger sample sizes and examining populations from across the world are essential for the exploration of the association between breast cancer risk and ERCC1 gene polymorphisms, other DNA repair gene polymorphisms, and even the relevant haplotypes. This evidence concerns the gene ERCC1 and breast cancer.